RTP-based startup T3D offers hope to Alzheimer’s patients
RESEARCH TRIANGLE PARK, N.C. – In a landscape littered with disappointment in the battle against the global scourge of Alzheimer’s disease, an RTP-based company is offering a new chance for hope. T3D Therapeutics, a 7-year-old company started with loan help from the North Carolina Biotechnology Center, said today it is launching a Phase 2 clinical trial with its unique product candidate, T3D-959, to treat mild to moderate forms of Alzheimer’s disease (AD). T3D-959 is a chemically synthesized once-daily oral drug described as a brain-penetrating dual nuclear receptor agonist....
Read MoreNew Life-sciences Venture Contest To Award Top Grant Of $20K
WILMINGTON, N.C. – Life sciences and biotechnology business ventures in Southeastern North Carolina could get a boost through a new competition launched Tuesday by the N.C. Biotechnology Center Southeastern Office, in partnership with UNCW’s CIE. Entrepreneurs and companies can now apply for the NC BIONEER Venture Challenge, which aims to “raise the profile, increase the volume, and enhance the success of life science commercialization, entrepreneurs, and companies in the region,” according to the venture challenge website. The application period runs through Feb....
Read MoreEli Lilly returns to RTP with $470M plant for diabetes drugs
RESEARCH TRIANGLE PARK, N.C. – Global pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) plans to build a research facility in RTP, creating 462 jobs over the next five years, officials said Tuesday. The Indianapolis-based company will invest $474 million in the lab, which will produce drugs for diabetes. “This next-generation manufacturing facility will allow us to expand our capacity to make the Lilly medicines that are helping people with serious illnesses today and help us prepare for new medicines coming from our robust pipeline in the future,” Chairman and Chief...
Read MoreKBI Biopharma teams up with AbSci to promote each other’s technologies
RESEARCH TRIANGLE PARK, N.C. — KBI Biopharma, a biopharmaceutical cAbSci, the Protein Printing™ company with a best-in-class E. coli cell line for rapid and low-cost biomanufacturing of complex biotherapeutics, today announced the completion of a $10.4M Series D financing led by KBI Biopharma and JSR Life Sciencesract services organization with offices in Durham and RTP, has entered into an exclusive co-marketing agreement with the Washington-based biopharma tech company, AbSci. The uptick: both get the privilege to jointly market and promote each other’s...
Read More410 Medical’s LifeFlow device wins healthcare fans, major contract
RALEIGH — A hand-held fluid resuscitation device developed by Durham start-up 410 Medical has been generating major buzz and billings for its unique design and pot LifeFlow is a hand-operated infuser that combines a syringe, automatic check valve and high-flow tubing set. It was designed by physician Mark Piehl at WakeMed Health & Hospitals in Raleigh to help a single caregiver inject resuscitating fluids quickly and easily with less stress in emergency situations. The company says LifeFlow lowers risk of organ failure due to its ability to deliver fluids more efficiently. ential...
Read MoreMedical device firm Contego Medical lands $22.3M from investors
RALEIGH, N.C. – Contego Medical, a Raleigh-based medical device firm that received FDA approval for two systems targeting neurovascular, coronary and peripheral vascular disease, has landed $22 million from 10 investors. Contego disclosed the funding in an SEC filing. In 2018, Conteo Medical received FDA approval for: The Vanguard IEP Peripheral Balloon Angioplasty System with Integrated Embolic Protection.The “first” filter-based Integrated Embolic Protection (IEP) device, the Paladin Carotid PTA Balloon System. Contego CEO Ravish Sachar signed the filing. The...
Read More
Follow Us!